Publications by authors named "Daniel Pinho Cassiano"
Lack of efficacy of oral N-acetylcysteine in the treatment of facial melasma in women: a randomized, double-blind, placebo-controlled clinical trial.
Melissa de Almeida Corrêa Alfredo Ingrid Rocha Meireles Holanda Daniel Pinho Cassiano Ana Cláudia Cavalcante Espósito Paula Basso Lima
An Bras Dermatol
August 2024
Oral ketotifen associated with oral tranexamic acid for the treatment of facial melasma in women: A randomized, double-blind, placebo-controlled trial.
Ana Clara Ladeira Cruz Daniel Pinho Cassiano Mackerley Bleixuvehl de Brito Ana Cláudia Cavalcante Espósito Karime Hassun
J Eur Acad Dermatol Venereol
January 2025
Efficacy of oral 5 mg melatonin in the treatment of facial melasma in women: A double-blind, randomized, placebo-controlled clinical trial.
Ingrid Rocha Meireles Holanda Melissa de Almeida Corrêa Alfredo Daniel Pinho Cassiano Ana Cláudia Cavalcante Esposito Paula Basso Lima
J Eur Acad Dermatol Venereol
July 2024
Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
Daniel Pinho Cassiano Ana Cláudia Cavalcante Espósito Karime Marques Hassun Mariana Modesto Dantas de Andrade Lima Emerson Vasconcelos de Andrade Lima
Indian J Dermatol Venereol Leprol
December 2022
Background Melasma is an acquired dyschromia with several histologic alterations in the epidermis, basement membrane and upper dermis. The treatment of melasma is challenging due to the irregular response and chronicity of the disease. To date, there are no curative strategies, largely due to the limited understanding of the intrinsic effects of each treatment.
View Article and Find Full Text PDF